Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive

Back to Forecasting
CLFActive

Will CLF reduce net debt by at least $1B from year-end 2025 levels by December 31, 2026?

Resolves March 15, 2027(254d)
IG: 0.64

Current Prediction

10%
Likely No
Model Agreement98%
Predictions9 runs
Last UpdatedApril 21, 2026

Prediction History

Initial
30%
Apr 5
-20pp
Current
10%
Apr 21
Q1 2026 earnings update (2026-04-21)

Q1 net debt moved the wrong direction: long-term debt +$510M QoQ ($850M senior notes + $507M ABL draw), cash -$12M, equity -$304M. POSCO softened ('less in a hurry'), HBI withdrawn from divestitures. Deleveraging redundancy narrowed to operating cash flow alone. $1B reduction now requires ~$1.5B swing from current trajectory in 8 months. Ensemble moved from 0.30 to 0.10.

Why This Question Matters

CLF's $7.3B debt against $37M EBITDA creates an existential overhang. Multiple deleveraging paths exist (POSCO equity, asset sales, EBITDA recovery), but no single path is sufficient alone. Achieving $1B+ net debt reduction would demonstrate that multiple levers are executing simultaneously. Failure would indicate the financial distress may be more structural than cyclical, validating the current discount.

FUNDING_FRAGILITYCAPITAL_DEPLOYMENT

Prediction Distribution

0%25%50%75%100%
opus
sonnet
haiku
Range: 8%12%Aggregate: 10%
Individual Predictions(9 runs)
opusRun 1
8%

Q1 made $1B net debt reduction by year-end effectively impossible absent POSCO closing AND asset sales AND massive FCF. Long-term debt grew $510M in Q1 alone — so the starting point is now $1.5B worse than the YE2025 baseline implied. Getting to -$1B net debt YoY requires either ~$1.5B of asset sales/equity raises or three consecutive quarters of extraordinary FCF. With POSCO softened, HBI retained, and Q1 FCF negative, the math doesn't work. Probability is very low — around 8%. Only way this resolves YES is a POSCO close + Stelco sale + strong FCF all in 8 months.

Q1 debt +$510M makes starting point $1.5B worsePOSCO softened, HBI withdrawn — two major deleveraging pillars weakenedMath requires ~$1.5B swing from current path
opusRun 2
10%

Consider the most optimistic plausible path: Q2 FCF +$400M (AR release as guided), Q3 FCF +$300M (outage-light EBITDA $300M), Q4 FCF +$200M, POSCO $700M in H2 = cumulative $1.6B from Q2-Q4. Less the Q1 debt increase of $510M = $1.1B net reduction. It's mathematically possible but requires near-perfection: CFO's Q2 FCF promise must deliver, Q3 EBITDA must hit >$300M credibility bar, AND POSCO must close. With POSCO urgency softened, the last leg becomes much harder. ~10% probability.

Even optimistic path barely crosses $1B net reductionPOSCO close is the swing factor — now lower probabilityQ3 EBITDA >$300M must also hit
opusRun 3
9%

The baseline at 30% already assumed POSCO + asset sales + EBITDA recovery executing in parallel. All three got worse: POSCO softened, HBI withdrawn, and Q1 debt growth of $510M means the delta needed is now $1.5B. The tariff environment and commodity strength don't change this — they support FCF but FCF alone can't do $1.5B in 8 months. At 50:1 operating leverage, Q2-Q4 FCF would need ~$1.2B cumulative, which implies EBITDA well above $900M for Q2-Q4 combined. Possible but requires the high-end catalyst scenario. ~9%.

All three deleveraging pillars got worseQ2-Q4 FCF needs ~$1.2B cumulativeRequires high-end catalyst scenario across the board
sonnetRun 1
12%

Baseline was 30% — now dramatically lower. Q1 debt +$510M, POSCO softened, HBI withdrawn. The only way this resolves YES is: Q2 FCF delivers $400M (AR release), Q3/Q4 EBITDA averages $300M+ with modest capex, AND POSCO closes with $700M equity in H2. With POSCO softened that last leg is <30%. Cumulative probability of the full chain is around 10-15%. I'll price at 12%.

Starting point $1.5B worse than baselinePOSCO probability cut roughly in halfNeed chain of 3 improbable events
sonnetRun 2
10%

This market has moved from a difficult bet (30%) to a very difficult one. CLF raised $850M in senior notes during Q1, which suggests they're planning to service debt rather than pay it down in the near term. Issuing $850M of new term debt for a company that needs to reduce net debt by $1B is paradoxical unless it's refinancing (which it partially is). But the gross debt rose $510M net, indicating real incremental borrowing. Probability ~10%.

$850M senior notes issuance is not pre-deleveragingNet debt actually grew Q1Gap to target expanded
sonnetRun 3
9%

With Q1 headed the wrong direction, POSCO softened, and asset sales pipeline reduced (HBI out), this is now a tail scenario requiring near-everything-right. CLF's capex stayed at $700M, interest ~$460M, pension $125M — operational cash flow must clear $1.3B just to flat-line net debt. Reducing by $1B requires $2.3B+ of operating cash + asset sales. Very unlikely in 8 months from here. 9%.

CLF needs $2.3B+ cash generation post-Q1 to hit targetOperating model can't fund this aloneAsset-sale optionality reduced
haikuRun 1
10%

Baseline 30% was already bearish. Q1 debt +$510M pushes target much further out of reach. POSCO softening removes the main deleveraging lever. ~10%.

Q1 debt grew $510MPOSCO softenedTarget $1B further away
haikuRun 2
11%

With POSCO urgency down and debt up, $1B net reduction by Dec 2026 is very unlikely. Requires POSCO + strong FCF + no further debt draws. 11%.

Requires POSCO + FCF + no drawsAll three look harder post-Q1Tight window
haikuRun 3
9%

Q1 set the deleveraging thesis back significantly. Tail scenario requiring perfect execution. 9%.

Q1 set thesis backTail-scenario execution neededTime compressed

Resolution Criteria

Resolves YES if CLF's net debt (total debt minus cash and equivalents) as of December 31, 2026 is at least $1B lower than year-end 2025 net debt as reported in the FY2025 10-K. Resolves NO if net debt reduction is less than $1B.

Resolution Source

CLF FY2026 10-K filing or Q4 2026 earnings release balance sheet

Source Trigger

Balance sheet deleveraging trajectory — non-core asset sales ($425M) and POSCO equity ($700M) as paths

stress-scannerFUNDING_FRAGILITYHIGH
View CLF Analysis

Full multi-lens equity analysis